UraniumX Discovery ( STMXF ) has successfully closed the first tranche of its non-brokered private placement , according to its news release dated March 18, 2026. The company issued 6.18M flow-through shares (FT Shares) at a price of $0.17 each, generating gross proceeds of $1.05M. These FT shares qualify as "flow-through shares" under subsection 66(15) of the Income Tax Act (Canada), and the proc...
UraniumX Discovery ( STMXF ) has successfully closed the first tranche of its non-brokered private placement , according to its news release dated March 18, 2026. The company issued 6.18M flow-through shares (FT Shares) at a price of $0.17 each, generating gross proceeds of $1.05M. These FT shares qualify as "flow-through shares" under subsection 66(15) of the Income Tax Act (Canada), and the proceeds will be allocated to incur Canadian exploration expenses, which will be renounced to subscribers in an amount no less than the subscription price, effective December 31, 2027. The funds will support ongoing and planned exploration programs at the Murphy Lake and Zoo Bay properties. Additionally, all securities issued are subject to a statutory hold period of four months and one day, expiring on August 1, 2026. The company also paid finders' fees totaling $73.5K in connection with the offering. More on UraniumX Discovery Corp. Financial information for UraniumX Discovery Corp.
In this article NVO .STOXX NVO Follow your favorite stocks CREATE FREE ACCOUNT Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4% after England's drug price regulator recommended the use of its best-selling drug Wegovy to prevent heart attacks and strokes. Wegovy is mainly a weight loss treatment but it is also approved for reducing the risk of major cardio...
In this article NVO .STOXX NVO Follow your favorite stocks CREATE FREE ACCOUNT Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4% after England's drug price regulator recommended the use of its best-selling drug Wegovy to prevent heart attacks and strokes. Wegovy is mainly a weight loss treatment but it is also approved for reducing the risk of major cardiovascular events in people living with overweight or obesity. The new recommendation the National Institute for Health and Care Excellence (NICE), England's drug price regulator, will significantly expand access to Wegovy on the country's National Health Service (NHS). The regulator, which assesses a medicine's cost-effectiveness, recommended semaglutide, the active ingredient in Wegovy and diabetes treatment Ozempic, as an option for adults who have previously had a heart attack, a stroke, or a serious circulation problem in the legs and who have a body mass index (BMI) of at least 27. Novo's Copenhagen-listed shares were last seen up 2% in morning trading, paring some earlier gains. The pan-European blue-chip index Stoxx 600 was up 2.1%. This is a breaking news story. Please refresh for updates. Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Malaysia’s government has said it “strongly denies” a claim made in a news report that Prime Minister Anwar Ibrahim sought to delay the release of findings from an investigation into the country’s anti-corruption chief, and will take legal action over the allegation. The latest claim has sharpened scrutiny of Anwar, whose reformist image and anti-corruption credentials have come under strain amid ...
Malaysia’s government has said it “strongly denies” a claim made in a news report that Prime Minister Anwar Ibrahim sought to delay the release of findings from an investigation into the country’s anti-corruption chief, and will take legal action over the allegation. The latest claim has sharpened scrutiny of Anwar, whose reformist image and anti-corruption credentials have come under strain amid a series of allegations involving the Malaysian Anti-Corruption Commission (MACC) and its chief...
(RTTNews) - goeasy Ltd. (EHMEF, GSY.TO), a Canadian consumer lender, on late Tuesday reported a loss in its fourth quarter, compared to prior year's profit, hit by LendCare-related charges, elevated credit losses, and higher expenses, amid nearly flat revenues.
(RTTNews) - goeasy Ltd. (EHMEF, GSY.TO), a Canadian consumer lender, on late Tuesday reported a loss in its fourth quarter, compared to prior year's profit, hit by LendCare-related charges, elevated credit losses, and higher expenses, amid nearly flat revenues.
In this article PONY Follow your favorite stocks CREATE FREE ACCOUNT A Baidu Inc. Apollo Go autonomous driving electric vehicle displayed at the International Automotive and Supply Chain Expo in Hong Kong, June 12, 2025. Chan Long Hei | Bloomberg | Getty Images Baidu's Apollo Go robotaxis reportedly stopped mid-traffic, trapping passengers and resulting in highway collisions on the streets of the ...
In this article PONY Follow your favorite stocks CREATE FREE ACCOUNT A Baidu Inc. Apollo Go autonomous driving electric vehicle displayed at the International Automotive and Supply Chain Expo in Hong Kong, June 12, 2025. Chan Long Hei | Bloomberg | Getty Images Baidu's Apollo Go robotaxis reportedly stopped mid-traffic, trapping passengers and resulting in highway collisions on the streets of the Chinese city of Wuhan on Tuesday, according to videos shared on social media . The incident was confirmed by a statement published on the official Weibo account of the Wuhan local traffic police department, which acknowledged reports of multiple Apollo Go vehicles that stalled in the middle of a road. "Upon investigation, preliminary findings suggest system malfunctions as the cause of the incident," read the police department's statement in Chinese, translated by CNBC. The statement added that authorities had worked with Apollo Go staff to handle the initial situation, with the incident still undergoing further investigation. Passengers had safely exited the affected vehicles, it added. Chinese search giant Baidu , which owns and operates Apollo Go, did not immediately respond to CNBC's request for comment. Wuhan city is home to Apollo Go's largest robotaxi deployment in China, with more than 1,000 vehicles operating without human drivers. Baidu has invested in and ramped up its driverless ride-hailing unit much like its U.S. counterpart Alphabet has invested in and ramped up robotaxi service Waymo in the western part of the U.S.. Both have grown into leading robotaxi providers in an emerging industry that's recently tipped into the mainstream . Apollo Go also faces formidable competition from other Chinese autonomous vehicle makers in Asia, including WeRide and Pony.AI . Elon Musk's automaker Tesla is also developing driverless vehicles but is not yet operating a commercial robotaxi service outside of a limited pilot in Austin, Texas. Apollo Go already operates a commerci...